Alkermes (ALKS) Net Income (2010 - 2026)
Alkermes (ALKS) reported Net Income of -$66.5 million for Q1 2026, down 234.69% quarter-over-quarter from $49.4 million in Q4 2025.
Alkermes (ALKS) Net Income (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Net Income data on file, last reported at -$66.5 million in Q1 2026.
- Net Income for Q1 2026 came in at -$66.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$17.1 million (down 481.24% YoY), and the FY2025 annual result was $241.7 million, up 4868.43% from the prior year.
- Net Income eased to -$66.5 million in Q1 2026 per ALKS's latest filing, from $49.4 million in the prior quarter.
- Over five years, Net Income peaked at $96.9 million in Q4 2022 and troughed at -$66.5 million in Q1 2026.
- A 5-year average of -$15.6 million and a median of -$30.0 million in 2022 frame the typical range for Net Income.
- The sharpest annual moves came in 2022 and 2025: Net Income sank 1374.79% in 2022, then jumped 6347.91% in 2025.
- A 5-year view of Net Income shows it stood at $96.9 million in 2022, then slumped by 149.32% to -$47.8 million in 2023, then soared by 101.6% to $766000.0 in 2024, then jumped by 6347.91% to $49.4 million in 2025, then tumbled by 234.69% to -$66.5 million in 2026.
- Business Quant data shows ALKS's Net Income at -$66.5 million in Q1 2026, $49.4 million in Q4 2025, and $766000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 52.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.53 Mn |
| Dec 31, 2025 | 49.39 Mn |
| Dec 31, 2024 | 766,000.00 |
| Sep 30, 2024 | -414,000.00 |
| Jun 30, 2024 | -3.30 Mn |
| Mar 31, 2024 | -2.12 Mn |
| Dec 31, 2023 | -47.77 Mn |
| Sep 30, 2023 | -43.80 Mn |
| Jun 30, 2023 | -42.04 Mn |
| Mar 31, 2023 | -29.80 Mn |
| Dec 31, 2022 | 96.86 Mn |
| Sep 30, 2022 | -63.97 Mn |
| Jun 30, 2022 | -30.14 Mn |
| Mar 31, 2022 | -35.90 Mn |
| Dec 31, 2021 | 135.97 Mn |
| Sep 30, 2021 | -28.99 Mn |
| Jun 30, 2021 | 2.36 Mn |
| Mar 31, 2021 | -22.42 Mn |
| Dec 31, 2020 | -29.71 Mn |
| Sep 30, 2020 | -134,000.00 |